In vitro evaluation on a model of Blood Brain Barrier of Idebenone-loaded solid lipid nanoparticles

Journal of Nanoscience and Nanotechnology

Volumn 12, Issue 1, 2012, Pages 330-337

  Montenegro, L ^a   Trapani, A ^b   Latrofa, A ^b   Puglisi, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Blood Brain Barrier; Idebenone; MDCKII MDR1 cells; Solid lipid nanoparticles

Indexed keywords

BLOOD-BRAIN BARRIER; CELL MONOLAYERS; DELIVERY SYSTEMS; IDEBENONE; IN-VITRO; IN-VITRO EVALUATION; IN-VIVO; MEAN PARTICLE DIAMETER; NANOCARRIERS; OSMOLARITY; PARENTERAL ADMINISTRATION; PHASE INVERSION TEMPERATURE; PHYSIOLOGICAL PH; SIMULATED BODY FLUIDS; SINGLE PEAK; SOLID LIPID NANOPARTICLE (SLN); TRANSCELLULAR PATHWAY; WATER SOLUBLE COMPOUNDS;

BLOOD; LOADING; MONOLAYERS; NANOPARTICLES; ORGANIC SOLVENTS; PH;

INTEGRODIFFERENTIAL EQUATIONS;

ANTIOXIDANT; DRUG DERIVATIVE; IDEBENONE; LIPID; NANOCAPSULE; UBIQUINONE;

ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; CHEMISTRY; DIFFUSION; DOG; MATERIALS TESTING;

ANIMALS; ANTIOXIDANTS; BLOOD-BRAIN BARRIER; DIFFUSION; DOGS; LIPIDS; MATERIALS TESTING; NANOCAPSULES; UBIQUINONE;

EID: 84861142135     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2012.5174     Document Type: Conference Paper

References (37)

1. S. A. Wissing, O. Kaiser, and R. H. Muller, Adv. Drug Del. Rev. 56, 1257 (2004).
2. G. Montana, M. L. Bondì, and R. Carrotta, Bioconjugate Chem. 18, 302 (2007).
3. K. Ruckmani, M. Sivakumar, and P. A. Ganeshkumar, J. Nanosci. Nanotech. 6, 2991 (2006).
4. L. Priano, D. Esposti, R. Esposti, G. Castagna, C. De Medici, F. Fraschini, M. R. Gasco, and A. Mauro, J. Nanosci. Nanotech. 7, 3596 (2007).
5. J. Kreuter, Adv. Drug Deliv. Rev. 47, 65 (2001).
6. P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci, and C. Rossi, Adv. Drug Del. Rev. 59, 454 (2007).
7. M. L. Bondì, E. F. Craparo, G. Giammona, and F. Drago, Nanomedicine: NBM 5, 25 (2010).
8. Y. C. Kuo and H. H. Chen, J. Drug Target. 18, 447 (2010).
9. I. P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar, J. Control. Release 127, 97 (2008).
10. M. D. Joshi and R. H. Muller, Eur. J. Pharm. Biopharm. 71, 161 (2009).
11. R. H. Müller, K. Maëder, and S. Gohla, Eur. J. Pharm. Biopharm. 50, 161 (2000).
12. W. Mehnert and K. Mäder, Adv. Drug Del. Rev. 47, 165 (2001).
13. H. Bunjes, B. Siekmann, and K. Westesen, Submicron Emulsions in Drug Targeting and Delivery, edited by S. Benita, Harwood Academic Publishers, Amsterdam (1998), p. 175.
14. B. Siekmann and K. Westesen, Eur J Pharm Biopharm. 43, 104 (1996).
15. M. R. Gasco, U. S. Patent 5 250 236, 5 October (1993).
16. L. Montenegro, A. Campisi, M. G. Sarpietro, C. Carbone, R. Acquaviva, G. Raciti, and G. Puglisi, Drug Dev. Ind. Pharm. 37, 737 (2011).
17. L. Schols, C. H. Meyer, G. Schmid, I. Wihelms, and H. Przuntek, J. Neural. Trans. 68, 135 (2004).
18. I. Imada, T. Fujita, Y. Sugiyama, K. Okamoto, and Y. Kobayashi, Arch. Gerontol. Ger. 8, 323 (1989).
19. J. Schwarz and M. Weisspapir, U. S. Patent 2010129431 (2010).
20. N. Denora, V. Laquintana, A. Lopedota, M. Serra, L. Dazzi, G. Biggio, D. Pal, A. K. Mitra, A. Latrofa, G. Trapani, and G. Liso, Pharm. Res. 24, 1309 (2007).
21. L. M. V. Madgula, B. Avula, Y.-B. Yu, Y.-H. Wang, F. Tchantchou, S. Fisher, Y. Luo, I. A. Khan, and S. I. Khan, Planta Med. 76, 599 (2010).
22. H. Ouyang, T. E. Anderson, W. Chen, R. Nofsinger, B. Steffansen, and R. T. Borchard, J. Pharm. Sci. 98, 2227 (2007).
23. P. J. Gaillard and A. G. de Boer, Eur. J. Pharm. Sci. 12, 95 (2000).
24. L. Montenegro, C. Carbone, G. Condorelli, R. Drago, and G. Puglisi, Drug Dev. Ind. Pharm 32, 539 (2006).
25. G. Lukowski, J. Kasbohm, P. Pflegel, A. Illing, and H. Wulff, Int. J. Pharm. 196, 201 (2000).
26. J.-J. Wang, K. S. Liu, K. C. Sung, C. Y. Tsai, and J. Y. Fang, Eur. J. Pharm. Sci. 38, 138 (2009).
27. R. Yang, R. Gao, F. Li, H. He, and X. Tang, Drug Dev. Ind. Pharm. 37, 139 (2011).
28. A. Lopedota, A. Trapani, A. Cutrignelli, L. Chiarantini, E. Pantucci, R. Curci, E. Manuali, and G. Trapani, Eur. J. Pharm. Biopharm. 72, 509 (2009).
29. M. Haschizume, Y. Nagasawa, T. Suzuki, S. Kawashima, and M. Kamitakahara, Colloids Surf. B Biointerfaces. 84, 545 (2011).
30. M. B. Kannan, R. K. Singh Raman, F. Witte, C. Blawert, and W. Dietzel, J. Biomed. Mater. Res. B Appl. Biomater. 96, 303 (2011).
31. K. Westesen and H. Bunjees, Int. J. Pharm. 115, 129 (1995).
32. M. K. Lee, S. J. Lim, and C. K. Kima, Biomaterials 28, 2137 (2007).
33. S. A. Wissing, R. H. Muller, L. Manthei, and C. Mayer, Pharm. Res. 21, 400 (2004).
34. P. Izquierdo, J. Feng, J. Esquena, T. F. Tadros, J. C. Dederen, M. J. Garcia, N. Azemar, and C. Solans, J. Colloid. Interface Sci. 285, 388 (2005).
35. J. Mensch, J. Oyarzabal, C. Mackie, and P. Augustijns, J. Pharm. Sci. 98, 4429 (2009).
36. N. Denora, V. Laquintana, A. Trapani, A. Lopedota, A. Latrofa, J. M. Gallo, and G. Trapani, Mol. Pharm. 7, 2255 (2010).
37. A. Trapani, V. Laquintana, A. Lopedota, M. Franco, A. Latrofa, G. Talani, E. Sanna, G. Trapani, and G. Liso, Int. J. Pharm. 278, 91 (2004).